WHITTIER TRUST CO - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 141 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.

Quarter-by-quarter ownership
WHITTIER TRUST CO ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$38,309
-22.2%
1,212
+0.3%
0.00%0.0%
Q2 2023$49,248
+9.4%
1,2080.0%0.00%0.0%
Q1 2023$45,021
+6.9%
1,2080.0%0.00%0.0%
Q4 2022$42,133
-2.0%
1,208
+58.9%
0.00%0.0%
Q3 2022$43,000
+10.3%
7600.0%0.00%0.0%
Q2 2022$39,000
-29.1%
7600.0%0.00%0.0%
Q1 2022$55,000
-38.9%
7600.0%0.00%0.0%
Q4 2021$90,000
+69.8%
760
+93.4%
0.00%0.0%
Q3 2021$53,000
-17.2%
3930.0%0.00%0.0%
Q2 2021$64,000
+100.0%
3930.0%0.00%0.0%
Q1 2021$32,000
+52.4%
3930.0%0.00%
Q4 2020$21,000
+162.5%
3930.0%0.00%
Q3 2020$8,0000.0%3930.0%0.00%
Q2 2020$8,000
+60.0%
3930.0%0.00%
Q1 2020$5,000
-16.7%
3930.0%0.00%
Q4 2019$6,000
+20.0%
3930.0%0.00%
Q3 2019$5,000
-16.7%
3930.0%0.00%
Q2 2019$6,000
-14.3%
3930.0%0.00%
Q1 2019$7,000
+40.0%
3930.0%0.00%
Q4 2018$5,000
-54.5%
3930.0%0.00%
Q3 2018$11,0000.0%3930.0%0.00%
Q2 2018$11,0003930.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 744,160$54,078,0005.79%
Discovery Value Fund 986,173$71,665,0005.28%
Ally Bridge Group (NY) LLC 60,000$4,360,0003.23%
MPM BioImpact LLC 159,409$11,584,0003.11%
ARK Investment Management 8,981,029$652,651,0002.72%
Elmwood Wealth Management, Inc. 67,599$4,912,0002.52%
Nikko Asset Management Americas, Inc. 2,872,269$192,442,0001.41%
Frazier Life Sciences Management, L.P. 203,684$14,802,0001.26%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$8,098,0001.22%
Merlin Capital, Inc 11,575$841,0001.11%
View complete list of INTELLIA THERAPEUTICS INC shareholders